Rhabdoid Tumors Are Sensitive to the Protein-Translation Inhibitor Homoharringtonine
Thomas P. Howard, Elaine M. Oberlick, Matthew G. Rees, etc. Clin Cancer Res. 2020 Sep 15; 26(18): 4995–5006.
The indenoisoquinoline LMP517: a novel antitumor agent targeting both TOP1 and TOP2
Laetitia Marzi, Yilun Sun, Shar-yin N. Huang, etc. Mol Cancer Ther. 2020 Aug; 19(8): 1589–1597.
Targeting triple-negative breast cancers with the Smac-mimetic birinapant
Najoua Lalaoui, Delphine Merino, Goknur Giner, etc. Cell Death Differ. 2020 Oct; 27(10): 2768–2780.
Efficacy of a new oncolytic adenovirus armed with IL-13 against oral carcinoma models
Kai-Liang Zhang, Rui-Ping Li, Bao-Ping Zhang, etc. Onco Targets Ther. 2019; 12: 6515–6523.
Empowering therapeutic antibodies with IFN-α for cancer immunotherapy
Jun Guo, Yu Xiao, Ramesh Iyer, etc. PLoS One. 2019; 14(8): e0219829.
Aryl hydrocarbon receptor acts as a tumor suppressor in a syngeneic MC38 colon carcinoma tumor model
Poonam Yakkundi, Eleanor Gonsalves, Maria Galou-Lameyer, etc. Hypoxia (Auckl). 2019; 7: 1–16.